Morcellation and Myomas: Balancing Decisions Around Minimally Invasive Treatments for Fibroids

Overview

Journal J Surg Oncol

Specialties General Surgery
Oncology

Date 2016 Jan 16

PMID 26768314

Citations 4

Authors

Matthew T Siedhoff

Kenneth H Kim

Affiliations

Soon will be listed here.

Abstract

Minimally invasive surgery (MIS) is increasingly being used to treat uterine fibroids because of the significant patient and societal benefits of these techniques over traditional laparotomy. Morcellation affords the removal of large fibroids in MIS but carries the risk of disseminating occult malignant tissue. The benefits of MIS for treating fibroids must be carefully weighed against its risks of morcellation.

Citing Articles

Getting square pegs out through round holes: A survey of Australian and New Zealand Gynaecologists regarding specimen retrieval.

Bryant-Smith A, Lowe J, Lam A Aust N Z J Obstet Gynaecol. 2022; 62(6):894-900.

PMID: 36225109 PMC: 10092616. DOI: 10.1111/ajo.13618.

Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route.

Kim A, Boyd L, Ringel N, Meyer J, Bennett G, Lerner V PLoS One. 2021; 16(2):e0246807.

PMID: 33561167 PMC: 7872248. DOI: 10.1371/journal.pone.0246807.

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.

Huo L, Wang D, Wang W, Cao D, Yang J, Wu M Front Oncol. 2020; 10:647.

PMID: 32477938 PMC: 7240040. DOI: 10.3389/fonc.2020.00647.

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

Park J, Lee J, Lee H, Lee J, Moon S, Kang S J Gynecol Oncol. 2017; 28(3):e28.

PMID: 28382795 PMC: 5391391. DOI: 10.3802/jgo.2017.28.e28.